Ritholtz Wealth Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.8M Buy
189,431
+45,763
+32% +$1.04M 0.07% 191
2026
Q1
$3.07M Buy
143,668
+42,553
+42% +$886K 0.05% 268
2025
Q4
$2.16M Buy
+101,115
New +$2.07M 0.04% 333
2025
Q3
Sell
-11,866
Closed -$170K 1089
2025
Q2
$170K Sell
11,866
-12,253
-51% -$168K ﹤0.01% 929
2025
Q1
$349K Buy
24,119
+10,236
+74% +$145K 0.01% 698
2024
Q4
$182K Buy
+13,883
New +$192K 0.01% 819

Other funds holding MD

Ritholtz Wealth Management's MD Position: Q2 2026 in Review

Ritholtz Wealth Management increased its Pediatrix Medical (MD) stake by 32% in Q2 2026, buying an estimated $1.04M and bringing the position to 189,431 shares worth $4.8M. The position accounts for 0.07% of the portfolio, ranked #191.

Ritholtz Wealth Management first reported a position in MD in Q4 2024 and has held it in 6 quarters since. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Ritholtz Wealth Management held 189,431 shares of Pediatrix Medical worth $4.8M as of Q2 2026.
  • Ritholtz Wealth Management bought 45,763 Pediatrix Medical shares in Q2 2026, an estimated $1.04M.
  • Pediatrix Medical made up 0.07% of Ritholtz Wealth Management's portfolio in Q2 2026, its #191 holding.
  • Ritholtz Wealth Management first reported a position in Pediatrix Medical in Q4 2024 and has held it in 6 quarters since.
  • 305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.